Tarsus Pharmaceuticals
$70.22
12
+$0.07+0.1% Today
Statistics
Day High
72.14
Day Low
69.58
52W High
85.25
52W Low
38.51
Volume
220,354
Avg. Volume
589,021
Mkt Cap
2.99B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12MayExpected
Expected EPS
-0.289222
Actual EPS
N/A
Financials
-14.72%Profit Margin
Unprofitable902.72MRevenue
-132.84MNet Income
Analyst Ratings
$96.60Average Price Target
The highest estimate is 105.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TARS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Abbvie
ABBV
Mkt Cap385.18B
Bausch Health Companies
BHC
Mkt Cap2.62B
Alcon
ALC
Mkt Cap36.88B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Rogers
ROG
Mkt Cap1.57B
Pfizer
PFE
Mkt Cap140.15B
About
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Show more...
CEO
Dr. Bobak R. Azamian M.D.
Employees
323
Country
US
ISIN
US87650L1035
Listings
0 Comments
Share your thoughts
FAQ
What is Tarsus Pharmaceuticals stock price today?▼
The current price of TARS is $70.22 USD — it has increased by +0.1% in the past 24 hours. Watch Tarsus Pharmaceuticals stock price performance more closely on the chart.
What is Tarsus Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tarsus Pharmaceuticals stocks are traded under the ticker TARS.
Is Tarsus Pharmaceuticals stock price growing?▼
TARS stock has risen by +4.85% compared to the previous week, the month change is a -7.04% fall, over the last year Tarsus Pharmaceuticals has showed a +43.51% increase.
What is Tarsus Pharmaceuticals market cap?▼
Today Tarsus Pharmaceuticals has the market capitalization of 2.99B
When is the next Tarsus Pharmaceuticals earnings date?▼
Tarsus Pharmaceuticals is going to release the next earnings report on May 12, 2026.
What were Tarsus Pharmaceuticals earnings last quarter?▼
TARS earnings for the last quarter are -0.2 USD per share, whereas the estimation was -0.09 USD resulting in a -115.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Tarsus Pharmaceuticals revenue for the last year?▼
Tarsus Pharmaceuticals revenue for the last year amounts to 902.72M USD.
What is Tarsus Pharmaceuticals net income for the last year?▼
TARS net income for the last year is -132.84M USD.
How many employees does Tarsus Pharmaceuticals have?▼
As of April 01, 2026, the company has 323 employees.
In which sector is Tarsus Pharmaceuticals located?▼
Tarsus Pharmaceuticals operates in the Health Care sector.
When did Tarsus Pharmaceuticals complete a stock split?▼
Tarsus Pharmaceuticals has not had any recent stock splits.
Where is Tarsus Pharmaceuticals headquartered?▼
Tarsus Pharmaceuticals is headquartered in Irvine, US.